Optimization of culture conditions for stable expression of recombinant fc-fused human extracellular CD99 in HEK293T cells
Authors:
- 19 August 2022
- journal article
- research article
- Published by Elsevier in Protein Expression and Purification
- Vol. 200, 106151
Abstract
No abstract availableKeywords
Funding Information
- National Research Council of Thailand (NRCT5-RSA63004-06, NRCT808/2563, RGNS 64-068, RGNS63-069)
- Chiang Mai University
This publication has 30 references indexed in Scilit:
- Introduction to current and future protein therapeutics: A protein engineering perspectiveExperimental Cell Research, 2011
- Production, Characterization, and Functional Analysis of Newly Established CD99 Monoclonal Antibodies MT99/1 and MT99/2Hybridoma, 2007
- CD99-Positive “Ewing's Sarcoma” from Mouse Bone Marrow–Derived Mesenchymal Progenitor Cells?Cancer Research, 2006
- Advanced genetic strategies for recombinant protein expression in Escherichia coliJournal of Biotechnology, 2005
- CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual diseaseLeukemia, 2004
- CD99 plays a major role in the migration of monocytes through endothelial junctionsNature Immunology, 2002
- T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen densityInternational Immunology, 1999
- The biochemical characterization of E2, a T cell surface molecule involved in rosettesEuropean Journal of Immunology, 1989
- The MIC2 gene product: Epitope mapping and structural prediction analysis define an integral membrane proteinMolecular Immunology, 1989
- MIC2 : a human pseudoautosomal genePhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1988